Drug Information Association Logo

Regulatory Affairs Part I: The IND Phase

« Back to Listing

Overview 

Learn about FDA regulations and expectations for the content, submission, and review of Investigational New Drug (IND) Products and the importance of regulatory strategy. The course focuses on drug and well characterized biological products and not the regulatory process for devices, generic products, or traditional biologics.

Contact your regional office for future dates and locations.
« Back to Listing Back To Top